Vitamin D Receptor – TaqI Variant (VDR)

Product detailed description

The VDR TaqI genetic test identifies an inherited variant in the vitamin D receptor (VDR) gene. This gene encodes a receptor that enables the body to respond to the active form of vitamin D, which plays an essential role in calcium absorption, bone health, and normal immune system function.

The VDR (Vitamin D Receptor) gene is involved in regulating the biological effects of vitamin D throughout the body. Through this receptor, vitamin D influences several important processes, including calcium and phosphorus metabolism, cellular functions, and immune responses.

The TaqI genetic variant (rs731236) is one of the most extensively studied polymorphisms in the VDR gene. Scientific research has investigated its potential associations with individual differences in vitamin D-related biological responses and certain health outcomes. However, its clinical significance remains uncertain.

VDR TaqI genetic testing provides information about inherited genetic characteristics of the vitamin D receptor and may contribute to a better understanding of genetic factors being studied in relation to vitamin D signaling.

What does the test detect?

• The presence of the TaqI genetic variant (rs731236) in the VDR gene.

• Whether the variant is present in one or both copies of the gene.

• Genetic information related to the vitamin D receptor.

• Inherited genetic differences investigated in relation to the body's biological response to vitamin D.

The VDR TaqI genetic test does not measure current vitamin D levels or reliably determine vitamin D deficiency or individual supplementation requirements. Vitamin D status is assessed through blood testing for 25-hydroxyvitamin D (25-OH vitamin D).